Clinicopathologic characteristics of prefibrotic-early primary myelofibrosis in Chinese patients

Xubo Gong1, Xingguo Lu1, Xibin Xiao2

  • 1Department of Clinical Laboratory, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.

Human Pathology
|January 11, 2014
PubMed

Insights

Clinicopathologic features of prefibrotic-early primary myelofibrosis (PEPMF) in Chinese patients differ from Western cohorts. This study highlights unique characteristics in Asian populations, necessitating further ethnic and geographic research.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Prefibrotic-early primary myelofibrosis (PEPMF) clinicopathologic features remain uncertain.
  • Limited data exists on PEPMF characteristics in Asian populations.

Purpose of the Study:

  • To analyze the clinicopathologic characteristics of Chinese patients with PEPMF.
  • To compare these features with predominantly white patients in Western countries.

Main Methods:

  • Analysis of 42 Chinese patients newly diagnosed with primary myelofibrosis (PMF) according to 2008 WHO criteria.
  • Evaluation of clinical, laboratory, and bone marrow trephine section findings.

Main Results:

  • Chinese PEPMF patients were more often male, younger, had lower hemoglobin, less frequent splenomegaly, and longer progression times.
  • Bone marrow findings showed increased granulopoiesis but less frequent specific megakaryocyte abnormalities compared to Western cohorts.

Conclusions:

  • Clinicopathologic features of PEPMF in Chinese patients differ significantly from Western populations.
  • Further studies across diverse ethnic and geographic groups are crucial for a comprehensive understanding of PEPMF.